board of directors

company overview | management | board of directors | investors | medical advisory board

TransMolecular's board of directors bring a wealth of business experience in operations, management, business development, and financing of early through public stage biotechnology companies. The board members are instrumental in assisting the Company's management team in advising and developing the overall strategic direction of the Company.

E. Michael Egan
President, Chief Executive Officer and Member of
TransMolecular, Inc. Board of Directors

Lyle Hohnke, Ph.D.
Principal, Tullis-Dickerson & Co., Inc.

Gert Caspritz, Ph.D.
General Partner, TVM Capital

Frank Garcia
Easton Capital Investment Group

Hans Mueller, Ph.D.
HM Consulting

Nicholas C. Nicolaides, Ph.D., Chairman
President & CEO – Morphotek, Inc.